Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 8
Submit an article Journal homepage
114
Views
12
CrossRef citations to date
0
Altmetric
Commentary

Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective

A. C. Altamura Department of Psychiatry, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan, Italy
,
D. Armadoros BioVid CorporationPrinceton, New Jersey, USA
,
M. Jaeger BioVid CorporationPrinceton, New Jersey, USA
,
R. Kernish BioVid CorporationPrinceton, New Jersey, USA
,
J. Locklear AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, USA
&
H.-P. Volz Krankenhaus für Psychiatrie, Psychotherapie und Psychosomatische Medizin Schloss Werneck, Werneck, GermanyCorrespondence[email protected]
Pages 2271-2282 | Accepted 05 Jun 2008, Published online: 26 Jun 2008

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Martha Sajatovic, Faith DiBiasi & Susan N Legacy. (2017) Attitudes toward antipsychotic treatment among patients with bipolar disorders and their clinicians: a systematic review. Neuropsychiatric Disease and Treatment 13, pages 2285-2296.
Read now

Articles from other publishers (11)

Andreas Carlborg, Marcus Thuresson, Lena Ferntoft & Johan Bodegard. (2014) Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patients. Therapeutic Advances in Psychopharmacology 5:1, pages 13-21.
Crossref
Andreas Carlborg, Lena Ferntoft, Marcus Thuresson & Johan Bodegard. (2015) Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study. Bipolar Disorders 17:1, pages 76-85.
Crossref
Syed Mohiuddin. (2014) A Systematic and Critical Review of Model-Based Economic Evaluations of Pharmacotherapeutics in Patients with Bipolar Disorder. Applied Health Economics and Health Policy 12:4, pages 359-372.
Crossref
Julie C Locklear, Peter Wahlqvist, Urban Gustafsson, Mattias Udd, Liberty Fajutrao & Hans Eriksson. (2014) Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis. Journal of Comparative Effectiveness Research 3:4, pages 335-344.
Crossref
Julie C. Locklear, Berhanu Alemayehu, Robert S. Brody, Soheil Chavoshi, Ozgur Tunceli, David Kern & Willie R. Earley. (2013) Treatment Patterns, HealthCare Resource Utilization and Costs in Patients with Bipolar Disorder, Newly Treated with Extended Release or Immediate Release Quetiapine Fumarate using US Healthcare Administrative Claims Data. Clinical Therapeutics 35:12, pages 1923-1932.
Crossref
Lars Eriksson, Teresa Hallerbäck, Leif Jørgensen & Andreas Carlborg. (2012) Use of quetiapine XR and quetiapine IR in clinical practice for hospitalized patients with schizophrenia: a retrospective study. Therapeutic Advances in Psychopharmacology 2:6, pages 217-226.
Crossref
Charlotte Emborg, Teresa Hallerbäck, Leif Jörgensen & Andreas Carlborg. (2012) A retrospective study of clinical usage of quetiapine XR and quetiapine IR in outpatients with schizophrenia in Denmark. Human Psychopharmacology: Clinical and Experimental 27:5, pages 492-498.
Crossref
Fernanda Rosa, Andreas Schreiner, Pierre Thomas & Tarek Sherif. (2012) Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable. Clinical Drug Investigation 32:4, pages 267-279.
Crossref
Ahmed Okasha. (2011) The dilemma in the concept and the management of bipolar disorder. Middle East Current Psychiatry 18:4, pages 190-194.
Crossref
A. Carlo Altamura, Matteo Porcellana, Paola M. Marinaccio, Maria Ciabatti, Emanuela P. Nocito, Lorenzo Magri & Cinzia Bressi. (2011) Is it possible to assess subjective well-being among bipolar inpatients? An 18-week follow-up study. General Hospital Psychiatry 33:2, pages 185-190.
Crossref
A. Carlo Altamura & Ira D. Glick. (2010) Designing outcome studies to determine efficacy and safety of antipsychotics for ‘real world’ treatment of schizophrenia. The International Journal of Neuropsychopharmacology 13:07, pages 971-973.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.